10-97320267-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005479.4(FRAT1):c.814G>A(p.Asp272Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000453 in 1,589,814 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005479.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRAT1 | NM_005479.4 | c.814G>A | p.Asp272Asn | missense_variant | 1/1 | ENST00000371021.5 | NP_005470.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRAT1 | ENST00000371021.5 | c.814G>A | p.Asp272Asn | missense_variant | 1/1 | 6 | NM_005479.4 | ENSP00000360060.3 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000574 AC: 12AN: 209222Hom.: 0 AF XY: 0.0000433 AC XY: 5AN XY: 115570
GnomAD4 exome AF: 0.0000243 AC: 35AN: 1437464Hom.: 0 Cov.: 31 AF XY: 0.0000224 AC XY: 16AN XY: 713122
GnomAD4 genome AF: 0.000243 AC: 37AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | The c.814G>A (p.D272N) alteration is located in exon 1 (coding exon 1) of the FRAT1 gene. This alteration results from a G to A substitution at nucleotide position 814, causing the aspartic acid (D) at amino acid position 272 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at